Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

PROCTER & GAMBLE HEALTH LTD.

NSE : PGHLBSE : 500126ISIN CODE : INE199A01012Industry : Pharmaceuticals & DrugsHouse : Merck - MNC

BSE4749.20-60.95 (-1.27 %)

PREV CLOSE ( ) 4810.15

OPEN PRICE ( ) 4752.20

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 637

TODAY'S LOW / HIGH ( )4689.35 4795.65

52 WK LOW / HIGH ( )4600 5640

NSE4750.60-63.8 (-1.33 %)

PREV CLOSE( ) 4814.40

OPEN PRICE ( ) 4779.95

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 4750.60 (49)

VOLUME 32440

TODAY'S LOW / HIGH( ) 4683.00 4796.05

52 WK LOW / HIGH ( )4575 5642.85

Select year

(Rs.in Million)

Particulars

Jun 2023

Jun 2022

Jun 2021

Jun 2020

Dec 2018

Profit Before Tax

3142.00

2533.70

2332.80

3548.50

11375.70

Adjustment

414.90

273.10

408.90

-121.60

-9136.80

Changes In working Capital

-300.30

-473.00

412.20

-57.30

-502.60

Cash Flow after changes in Working Capital

3256.60

2333.80

3153.90

3369.60

1736.30

Cash Flow from Operating Activities

2360.00

1695.20

2472.60

2353.70

-1303.90

Cash Flow from Investing Activities

-215.00

-255.40

-322.70

1646.40

12697.20

Cash Flow from Financing Activities

-984.70

-2886.30

-3866.30

-8834.10

-301.20

Net Cash Inflow / Outflow

1160.30

-1446.50

-1716.40

-4834.00

11092.10

Opening Cash & Cash Equivalents

3193.90

4640.50

6356.90

11190.90

98.80

Cash & Cash Equivalent on Amalgamation / Take over / Merger

Cash & Cash Equivalent of Subsidiaries under liquidations

Translation adjustment on reserves / op cash balalces frgn subsidiaries

Effect of Foreign Exchange Fluctuations

Closing Cash & Cash Equivalent

4354.20

3194.00

4640.50

6356.90

11190.90